about
Reciprocal modulation of I (h) and I (TASK) in thalamocortical relay neurons by halothanePostnatal expression pattern of HCN channel isoforms in thalamic neurons: relationship to maturation of thalamocortical oscillations.Inducible and Deterministic Forward Programming of Human Pluripotent Stem Cells into Neurons, Skeletal Myocytes, and Oligodendrocytes.Optimized inducible shRNA and CRISPR/Cas9 platforms for in vitro studies of human development using hPSCs.Reconstruction of the mouse extrahepatic biliary tree using primary human extrahepatic cholangiocyte organoids.Cerebrospinal Fluid Biomarkers in Alzheimer's Disease-From Brain Starch to Bench and Bedside.Seizures after cerebrovascular events: risk factors and clinical features.Human T cells in silico: Modelling their electrophysiological behaviour in health and disease.G/A polymorphism at -258 of the hepatic glucokinase promoter is not associated with decreased birth weight in preterm neonates.Differential phospholipase C-dependent modulation of TASK and TREK two-pore domain K+ channels in rat thalamocortical relay neurons.Identification of the muscarinic pathway underlying cessation of sleep-related burst activity in rat thalamocortical relay neurons.Can semiology predict psychogenic nonepileptic seizures? A prospective study.Relevance of raised cerebrospinal fluid monocyte levels in patients with frontotemporal dementia.Conditional Manipulation of Gene Function in Human Cells with Optimized Inducible shRNA.Diagnostic Value of Diffusion Tensor Imaging and Positron Emission Tomography in Early Stages of Frontotemporal Dementia.Distinguishing neurocognitive deficits in adult patients with NP-C from early onset Alzheimer's dementia.Apraxia screening predicts Alzheimer pathology in frontotemporal dementiaImmune Cell Activation in the Cerebrospinal Fluid of Patients With Parkinson's DiseaseHemicrania continua in carotid artery dissection - symptomatic cases or linked pathophysiology?Generating microglia from human pluripotent stem cells: novel in vitro models for the study of neurodegeneration
P50
Q28573202-92469CA5-59A8-4931-AE46-4015E648C60FQ28583228-B88548C1-FC56-47D7-9F49-642C58E0AFB8Q33559698-C83D4C0A-8418-4E37-ADB9-BC44F69AA17AQ37545744-21328F01-BA05-4D16-BAA8-07485906E9E5Q38696818-509B9091-168E-4F96-A293-252392FF9D8CQ39432592-B9419324-FB03-409D-8048-445BE5A2918DQ39467101-6531D707-57BE-484A-A875-2E1B74DA272CQ39691538-D4F79C8D-C400-48E5-A08E-B8A7157BDA1AQ46807263-8682DF2E-5959-4F84-8AB4-DA49CC488CD0Q47736726-90D6F048-674E-4742-9426-1DC219A5905EQ48273977-A53266EC-8846-4B87-B46B-568A7DBCAAF9Q48310739-ADC0E064-5D6D-45AD-8029-2336D2A837C8Q50136575-EF4BF540-913F-43E7-825F-FA0868BAF1BBQ52364906-BB7F4F8A-DC08-4C38-8369-26D015C91AA8Q53419213-72329EA2-898C-44C8-B29E-7385D93FF058Q55287001-D0562BD7-10C2-4351-921C-C1D7706C8FADQ57284837-B9DD6D05-BA58-4F26-9DB9-6E45C5E8B5D9Q60949823-BA738445-2BB0-42D7-B972-4671131C1AA4Q89453458-EAEE36B2-C78A-4252-9C51-D66C9A140D0FQ92128638-758A97BE-6EFE-4985-95AA-7727901DA566
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0001-6259-6100
@en
name
Matthias Pawlowski
@ast
Matthias Pawlowski
@en
Matthias Pawlowski
@es
Matthias Pawlowski
@nl
type
label
Matthias Pawlowski
@ast
Matthias Pawlowski
@en
Matthias Pawlowski
@es
Matthias Pawlowski
@nl
prefLabel
Matthias Pawlowski
@ast
Matthias Pawlowski
@en
Matthias Pawlowski
@es
Matthias Pawlowski
@nl
P106
P21
P31
P496
0000-0001-6259-6100